Mentions
Extended reach
Total likes
Video views
AI synopsis
Several discussions emphasize the positive efficacy ratings reported in the publication, mentioning figures like 'effective at over 91%', which creates a sense of hope. For instance, users reference the low side effects and significant immune response, using terms like 'good safety profile' and 'promising results' to communicate their support. The tone is largely optimistic, indicating that participants view the vaccine as a viable solution in the pandemic landscape.
Many discussions express a positive view of the findings regarding safety and efficacy.
Users show a strong interest in the implications of the vaccine results and share insights related to the study.
While some posts show deep engagement with the scientific content, others simply share links without much discussion.
Overall, there is a consensus that the publication has significant implications for public health regarding COVID-19 vaccination.
Stigli rusi na the lancet Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/d4CftwFTij
แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/o07RnAKyXI https://t.co/uN0FxxDEMp
9/ Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine. (THE LANCET). https://t.co/50PofF26pF https://t.co/yYVhoHZLWt
Refencias https://t.co/z93s87eL4q https://t.co/sc22bCNWKh https://t.co/xFXFFMwVyI https://t.co/k4IT1k6Qlw https://t.co/zaEsxwV3TA https://t.co/rOKjXPxVzr (3/3) https://t.co/q3gsgvWoKu
y aquí están los datos duros publicados como información complementaria del paper: https://t.co/DKmv51JoVZ
Which Covid vaccine is the most effective? This video answers critical questions by comparing seven vaccines based on phase 3 trial data. We explore their effectiveness against variants and discuss the promising safety…
This week we will explore the safety and efficacy of recent COVID-19 vaccines, including the promising results from the rAd26 and rAd5 vector-based trials. Discover how these vaccines perform in real-world settings and…
RT @ThisDayinCovid: On this day in COVID history, February 2, 2021: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous pr…
On this day in COVID history, February 2, 2021: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia Source: The Lancet #COVID #OnThisDay
On this day in COVID history, February 2, 2021: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 t... Source: The Lancet https://www.thelancet.com/article/S0140-6736(21)00234-8/fulltext
@Azadi77 @Tim_Roehn @ManuelaSchwesig @vonderleyen @WELTAMSONNTAG Stimmt, es gibt hierzu auch Studien. Eine der bekanntesten Studien wurde in The Lancet im Jahr 2021 veröffentlicht: Studie: “Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3
@Pr_Chabriere_E 02/02/2021 "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia" - Le vaccin Spoutnik V efficace à plus de 91 %, selon la revue The Lancet https://t.co/918FTH3Uyu
@vieil_garde_ph @laurossignol @olivierveran 04/09/2020 La Tribune : Spoutnik V, le vaccin russe anti-Covid-19, produit une réponse immunitaire chez 100 % des patients testés (Article du Lancet) https://t.co/5jkl2LxdCl https://t.co/918FTH3Uyu
@Lancillotto810 @Rotelli_MD @LaBombetta76 https://t.co/Gq7KqqISdV https://t.co/pdD6YziZGE https://t.co/AUY6U7Jyem https://t.co/eh7miZi3d9 potrei copiartene un centinaio, ma come ti avevo chiesto dovresti portare tu evidenza.. Credo invece tu non sappia spiegarci come si imposti un RCT e come si usi PubMed. Datti al sugo.
First hint: The list of authors of the Sputnik V team's @TheLancet papers (e.g. https://t.co/vd1iB4XFwH): The majority of authors are from the Health Ministry's "Gamaleya Center", but some of them are from research institutions of Russia's Ministry of Defence (MOD) (4/19) https://t.co/hbUeXkFUJ0
@_ZhN_ @sincity8512 Коля, у тебя спор, ради спора, или ты преследуешь какую то цель? Например доказать, что все в НИИ Гамалея кретины? Про защиту от заражения, почитай их публикацию. https://t.co/DOIKwjpjWi
@ForeheadBoiii @Brewjew308 @Jim_Jordan Sure.. here is a link to a mRNA vaccine safety study that now goes nowhere: https://t.co/qy64MljDmF The Lancet is one of the biggest journals.. and I have literally hundreds of dead links where there once were peer-reviewed studies.. that is not normal
"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet" https://t.co/ujhXx8DvLk
Publicacion en the Lancet sobre la Vacuna Sputnik Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/wYkSFFi3V0
スプートニクはAZと同じベクター型。 引用文献にあった6ヵ月追跡論文の補足資料から。 摂取群の方がプラセボ群より全体数が3倍多いにしても、服半農の多さよ。血管系、各種臓器炎症など。 Sタンパクだからそらそうか。 https://t.co/yHiIwMSFdo https://t.co/Eiy2AALsag https://t.co/j22VMyygUy https://t.co/g1NhYAxmT4
No hacerle el feo a Spunik https://t.co/3IPjXnOMLs
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/pRL1HtpzxZ
@MivorV @nerzul_x @HristoStoichk8 @NGY91791017 @liberwill @EzDima1 Хотя бы вот. Дальше уж сами как-нибудь: https://t.co/J54aGOPOV8 https://t.co/3xfFJVfpHA https://t.co/1QhY8RTmrd
RT @guerreroespejo: #SputnikV: se desvanecen las dudas de la #vacuna con la publicación en el Lancet de los resultados preliminares de la f…
Результаты 3 фазы испытаний Спутник-V: эффективность 91,6% Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet https://t.co/yEwzATcbzL
3. All 3 vaccines have been proven (in clinical trials) to efficacious and safe, and there are reports in major international journals. - Sputnik: https://t.co/d7SnD6mlKW - Astrazeneca: https://t.co/8TZlARl5AF - Sinopharm:https://t.co/0DQHLtBtZH
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/9bj9gEc4n8 via @YouTube
RT @ereditsh: Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/5klyvIaB9x via @YouTube
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/5klyvIaB9x via @YouTube
@Herr__Meneutik Außerdem war das hier die mW wesentliche wiss Grundlage für #SputnikV https://t.co/HP4I6RVoQQ https://t.co/E5zpKKKUW1
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/9cRxhavDr0 via @YouTube
@cunnin6 @DrDoomOnly @V_MadnessMaster https://t.co/a37pzmoFH3 U redu, samo preliminarni rezultati treće faze testiranja ali efikasnost se ne može osporiti. Primer je Argentina. Prema delta varijanti adaptirani imunitet Sputnik V vakcinom je učinkovitiji u smislu prevencije bolničkog lečenja nasuprot Fajzera.
RT @carpe_diem0820: ロシアのスプートニクVの第3相試験の中間解析 COVID-19に対して91.6％の有効性 良好な忍容性 Safety and efficacy of an rAd26 and rAd5 vector-based heterologous…
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/VCsOIC8lgV via @YouTube
Ver "Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Explained" en YouTube https://t.co/RSh4ZoRMT9
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/mozGR9irhB via @YouTube
Because of the mutation vaccines don’t work , then deduct the side effects unknown ! Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/7jNWXuIZsy via @YouTube
https://t.co/vHGS2zqXDF
RT @PCribbett: https://t.co/JOszNjc0Kc
https://t.co/JOszNjc0Kc
Voici 2 études concernant l'efficacité de vaccin Russe et un article de Nature : https://t.co/fycAJieIGF https://t.co/3XbeFEQ6So https://t.co/gCQkCoWcqV https://t.co/E8oeSNL4ii
https://t.co/pFHb8V3w34
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/NGsXZUjUfn via @YouTube
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/nNe9BF6IfF via @YouTube
nanlambot at nandilim paningin ko sksksks https://t.co/R5MuTX2vUi
RT @AcidoBlamOK: @Maferba6_ https://t.co/J1y7TG4e81 Pense que pasaba menos con la Sputnik pero en fin.. es una ruleta rusa. https://t.co/2y…
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/8IB9TvYrCu via @YouTube
RT @Zirphire: Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/1Dpfbj5zZK
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/1Dpfbj5zZK
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/1sr9IHEIER via @YouTube
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @AcidoBlamOK: @Maferba6_ https://t.co/J1y7TG4e81 Pense que pasaba menos con la Sputnik pero en fin.. es una ruleta rusa. https://t.co/2y…
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
https://t.co/Qmr2UnonBK
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @DenisUltraSlim: แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
แปะลิงก์ 1) https://t.co/s4t6uyeaWt แปะลิงก์ 2) https://t.co/xw7IRCcGD4
RT @AcidoBlamOK: @Maferba6_ https://t.co/J1y7TG4e81 Pense que pasaba menos con la Sputnik pero en fin.. es una ruleta rusa. https://t.co/2y…
RT @AcidoBlamOK: @Maferba6_ https://t.co/J1y7TG4e81 Pense que pasaba menos con la Sputnik pero en fin.. es una ruleta rusa. https://t.co/2y…
@Maferba6_ https://t.co/J1y7TG4e81 Pense que pasaba menos con la Sputnik pero en fin.. es una ruleta rusa. https://t.co/2y8jwtiJvu
@soyalerojas La buena es que Sputnik es 91.6% efectiva, muy bajos efectis secundarios (0.3%) en una cohorte de 16000 sujetos. https://t.co/KGHVhbBYLO
@Alice_715 @BelyaevValentin https://t.co/Bqdcdq4sYY
https://t.co/4ASakXwLew Which VACCINE is the best Please watch very interesting Informative
วัคซีนโควิดชนิดไหน ยี่ห้อไหนดีที่สุด? | ประสิทธิภาพของวัคซีนและสายพันธ์ข... https://t.co/bI2Kh9n1b8 ผ่าน @YouTube
https://t.co/OL67DWGLsV
เปรียบเทียบวัคซีนโควิด วัคซีนเทพเทพจิงๆมั้ย https://t.co/VWOEVftm6e
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/mdJXnZ7CrH via @YouTube
วัคซีนโควิดชนิดไหน ยี่ห้อไหนดีที่สุด? | ประสิทธิภาพของวัคซีนและสายพันธ์ข... https://t.co/bI2Kh9n1b8 ผ่าน @YouTube
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/8IB9TvYrCu via @YouTube
Required viewing for anyone who thinks vaccines, or at least the ones we currently have, are the answer. https://t.co/xun3lQqbSV
RT @oranglaut: Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/gn8ldvCqUu via @YouTube
RT @oranglaut: https://t.co/gn8ldvCqUu
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/gn8ldvCqUu via @YouTube
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/hz3QGzRAq2 via @YouTube CONSIDER just how well does Media Press & Governments keep the nations citizens informed @ABCaustralia @abcnews
interesting. @ABCaustralia @bbc_uk @labourunionsuk @UKLabour @BBCBreaking @gedkearney @ALeighMP Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/hz3QGzRAq2 via @YouTube https://t.co/5AYh8WzAE2
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/hz3QGzRAq2 via @YouTube
@rosanna_357 "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet" https://t.co/1RdKoGE9Ku
https://t.co/4iDHM7OodG
La efectividad de las vacunas se reduce rápidamente a medida qué las mutaciones aumentan. Las conclusiones muestran que a menos que la mayoría de la población mundial sea complemente vacunada, el virus seguirá intensificándose y superando las vacunas https://t.co/mQTr3ZoNTt
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/tPiKgWHzFf
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/uCb0RLhDkj via @YouTube
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/TFiWhT62cM via @YouTube
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/xAJuYscOrj Спутник V безопасен и эффективен
https://t.co/Ce23NWQE2B https://t.co/IUH6JdzWdS
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet https://t.co/0QjOhkPCla
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/V2gBRvEsn9 via @YouTube
@analiticok Paper de fase 3 sputnik V. te marque la eficacia para evitar la enfermedad. Aca va el link https://t.co/g1lL32KP8j https://t.co/6YZ5IEbG0P
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/g4VRcAC6UU
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/m2yQWNGgZL via @YouTube #auspol #nswpol
Which #Covid #vaccine is the best? | #Vaccine #Effectiveness and #Variants Ex... https://t.co/KUasrdff2p via @YouTube
RT @reytheking1939: @RCR750 Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim ana…
Virus variants impact vaccine efficacy in terms of time + place. See https://t.co/nwI1misTj3 And https://t.co/kaLRiIws5z
https://t.co/1xOrBTA4e5
@Potterbek @SpaceTruckin_ @pcsrv @max_katz На вот: https://t.co/Ip97A6v6Vv
Link: https://t.co/dJex2YvIY2 https://t.co/AA2zSV2Rls #vacina #covid19 #coronavirus #pandemia #sputnik #vacinarussa #ciência #lipufrj #lip #ufrj
Which Covid vaccine is the best? | Vaccine Effectiveness and Variants Ex... https://t.co/N5FCW4FSbN via @YouTube
@Rob4005 @strauss_nina @sandervrielink @Breinbrouwsels https://t.co/A5qbQqeujs https://t.co/WI6iw1fJ0v https://t.co/QrGylUPghX https://t.co/8pCoaROjOq hoeveel wil je er nog hebben?
@OrdeVanRode @majavdBij @sandervrielink https://t.co/A5qbQqeujs https://t.co/WI6iw1fJ0v https://t.co/QrGylUPghX https://t.co/8pCoaROjOq hoeveel wil je er nog hebben?
RT @LuisZuritaG: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @LuisZuritaG: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/v9Lj40n6Vx
Reference: https://t.co/8f0CshGG2R
Reference: https://t.co/8f0CshGG2R
RT @zishansays: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a r…
@Melonhead999 Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet https://t.co/WS8EYYzaf5 #Sputnik #wato
@AndreaBovenga @MarkAmesExiled Bullshit: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/FPympHzPoy
@ngseer @traktor_bang https://t.co/215DzOlrJk
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine https://t.co/IkHljfUC5A
MEDICAL PRESS REALESEA by @TheLancet "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia" https://t.co/kMpeLI722o
@GWLarsson @AnderssonHome Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/LfjPedC01j
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet https://t.co/yi0UF2Negg
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine. Results of the trials have been published in @TheLancet in February 2021. https://t.co/qKsKoJTyZ6 #SputnikV #Russia #Kenya https://t.co/ORu6MZgVnw
@zztvcka @Mongol41433344 @HuJirui @trnk_c Prostě vezme srazeninu a nacpe si ji do žil a nakonec se s ní udusi. Já jsem v případě Sputnik V videl jen opublikovany článek v Lancet, kde to jen sumarizuji a tam nic extra co se týká vedlejších účinků https://t.co/6drqGrOyOz
https://t.co/gvQIlnGvMR
RT @PuruJarvi: Stigli rusi na the lancet Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine:…
RT @PuruJarvi: Stigli rusi na the lancet Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine:…
RT @PuruJarvi: Stigli rusi na the lancet Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine:…
RT @PuruJarvi: Stigli rusi na the lancet Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine:…
Stigli rusi na the lancet Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/d4CftwFTij
@Rainer_Rehak auf pubmed findest genug - hier eine Studie mit 21.000 Patienten https://t.co/TKiSpmxqXY das hier ia aus Lancet https://t.co/Xj8fAZrIiZ
@mikeTsenatek @percidae Daten: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/jpZPOtIBkK
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/ArNnRvWRZm
@DehesdinT @lemondefr Ça fait un moment que des résultats d'essais cliniques de phase 3 sont publics (il y a que BioNTech qui a un niveau de preuve similaire, ni AstraZeneca ni Janssen, encore moins les autres), il y a pas vraiment de doute sur l'efficacité, ni sur la sécurité. https://t.co/hOCNsFZlZD
@dyctiostelium @vigotess @Heraldos2 @StratCons @MarcelaSaebL https://t.co/q4zAnZtBZB
@dyctiostelium @Heraldos2 @StratCons @MarcelaSaebL DOI:https://t.co/3MiDUJ5Yce pero es eficacia, una disculpa.
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/l3q9UKy34s
@DJSiri You know that the SputnikV has pretty good reviews in the Lancet https://t.co/UmxWSZUrAg
Here are some articles on Sputnik V https://t.co/4TyhBqkF82 https://t.co/Q7eQCcAkeW
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/b6i3rkS9T2 https://t.co/0ldTGiCoWg - via Researcher (@ResearcherApp)
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine https://t.co/pPuUZU6hi2 #TunduLissu #BonfireAdventures
@AOberbaum @saschafrmberlin @TiloJung @BMG_Bund Dessen Wirksamkeit wurde doch schon seriös festgestellt https://t.co/NH0VstZJyK https://t.co/a06YmbaDZU Genauso seriös wie bei den anderen Impfstoffen zum Zeitpunkt der Bestellung.
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet https://t.co/qnrkyoux5L
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
@rutihersh תוצאות של החיסון ספוטניק V הרוסי פורסם בלנצט Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/G7fSCWZlmH
@UralterDrache Und wie ich beißen kann, wollte dich nur nicht ganz blamieren ;-)
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
2. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/suCWqDC2UM
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
RT @influenzer3: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a…
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/o07RnAKyXI https://t.co/uN0FxxDEMp
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysi… https://t.co/6ylxw3IvGT
@John05753392 @zaikaorit247 @galaxy_vizitor @Alek62547040 @cabletron2 https://t.co/NMGyU8NDxA 4. Февральская статья по Sputnik V "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia" в "The Lancet" от 20.02.2021: >>
Estudo fase III da Sputnik V: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/fJHmzYJnVQ
ロシアのウイルスベクターワクチン https://t.co/QilsacLcl7
RT @bobswede: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a ran…
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet https://t.co/hd2KvFZVa2
RT @ContraApostasia: #Safety and #efficacy of an #rAd26 and #rAd5 vector-based heterologous prime-boost #COVID19Vaccine: an interim analysi…
#Safety and #efficacy of an #rAd26 and #rAd5 vector-based heterologous prime-boost #COVID19Vaccine: an interim analysis of a randomised controlled phase 3 trial in #Russia https://t.co/QCr1WxeXaO © @sputnikvaccine https://t.co/uKIRld6eu8
hier geht es um Sputnik V. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/jwqjz2UOBJ
@PavelNovotnak @JaromirBosak Vakcína Sputnik V se podává intramuskulárně. https://t.co/ALSfUQm7w0
#Yoh_Yasushi_Check ロシアからの報告。アデノウイルスベクターワクチン。 Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysi… https://t.co/nRwuqVJ3xr
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/k7IjmlaOzi
Safety and Efficacy of an rAd26 and rAd5 Vector-Based Heterologous Prime-Boost COVID-19 Vaccine | comment: Peter Lin MD, CCFP https://t.co/gj69tNpSPu via @practiceupdate
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet - Sputnik V https://t.co/4Q9HDaxv8T
Another vaccine with 91% efficacy Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. https://t.co/tXu3K3cRGu
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/qwIjPBjcvS
@Si1verhawk @Binkuwa @ndyagif @Arshathz @aruni_t @ravirannaneliya @Minimalneg Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - https://t.co/anDMCdkGNm Published in Lancet, easily one of the topmost journals - https://t.co/D5URWPXhIq
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/TTif8H63aW
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet https://t.co/g6ZnhMdTIg
#COVID19 Free full text! #coronavirus #covidvaccine Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. https://t.co/2cf7wQv8XZ
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/zEuQ2jb7cs
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/4qjscQGElC
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/lDhLt4lWCl
@henning_ @zeitonline Mir fehlt die Übersicht, die ich bei anderen Impfstoffen gesehen habe ... z.B. bei Sputnik. https://t.co/3zs66DvO8H Also Kaplan-Meier und evtl. das Trial Profile. Lese lieber Tabellen als Texte ...
@PeterHotez Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021; (published online Feb 2.) https://t.co/kxvYUow8Oi
@puddles123456 @Petar_1 @RadisaMilosevi1 Tako jezgrovit odgovor me je naterao da ponovo pročitam članak iz časopisa The Lancet: "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia". Dakle, niste u pravu
RT @JHSPH_NCRC: In @TheLancet, Logunov et al present results of the trial of this adenoviral based vaccine with a prime boost regimen. The…
In @TheLancet, Logunov et al present results of the trial of this adenoviral based vaccine with a prime boost regimen. The primary outcome was number of patients with PCR-confirmed COVID-19 21 days after the first dose. https://t.co/2cNrPOmKML https://t.co/AktZ4y5cVu
RT @o_quinterock: El ensayo fase 3 en el que participaron casi 20.000 personas, sugiere que un régimen de dos dosis tiene una eficacia del…
Trend up+1: Logunov DY, ..., Gam-COVID-Vac Vaccine Trial Group (Lancet) __Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia__ https://t.co/QbL1MAMKKz
Para buscar frases usen CTRL+F (o 3 puntitos > buscar en la página) luego de haber traducido. El estudio provee link a + info: https://t.co/wX5UuwTLd1 En las pág. 6 y 7 está la tabla de registro de eventos adversos graves. En la 13 da detalles de los 2 fallecidos post aplicación. https://t.co/VZ0mfp4z1b
Moskau – Der adenovirusbasierte Impfstoff Gam-COVID-Vac, besser bekannt als Sputnik V, hat in der Phase-3-Studie, deren Ergebnisse jetzt im Lancet (2021; DOI: 10.1016/S0140-6736(21)00234-8) veröffentlicht wurden,..... https://t.co/0jTrI2jsxG via @dt_aerzteblatt
RT @Nebiros96: 9/ Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine. (THE LANCET). https://t…
RT @Nebiros96: 9/ Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine. (THE LANCET). https://t…
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/P8xdlT3jXL
RT @Nebiros96: 9/ Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine. (THE LANCET). https://t…
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/5uCO53LO8w
9/ Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine. (THE LANCET). https://t.co/50PofF26pF https://t.co/yYVhoHZLWt
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/mpZC6SZelU
@A_Ra_Berlin @DeiwyIzen @wrachgrach Вроде в приложенном пдф симптомы описаны, приложение 2 https://t.co/KytAezuZyc
@Mandronix @ntvde Beim Sputnik wundere ich mich über den ziemlich großen Ausschluss von Personen aus der Betrachtung für die Wirksamkeit. https://t.co/3zs66DvO8H Der Grundaufbau des Impfstoffs scheint jetzt eher sinnvoll zu sein und somit würde ein Impfung wohl schon sinn machen.
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
Revisamos en artículo fuente de esta infomación (Logunov et al, 2021 y encontramos que los resultados publicados son de #Eficacia https://t.co/mMMF7lluMo
journée promo vaccin russe : composants du vaccin https://t.co/5TZoNF6WDz
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @InmunoUnicornio: Refencias https://t.co/z93s87eL4q https://t.co/sc22bCNWKh https://t.co/xFXFFMwVyI https://t.co/k4IT1k6Qlw https:…
RT @InmunoUnicornio: Refencias https://t.co/z93s87eL4q https://t.co/sc22bCNWKh https://t.co/xFXFFMwVyI https://t.co/k4IT1k6Qlw https:…
ロシア rAd26およびrAd5ベクターベースの異種プライムブーストCOVID-19ワクチンの安全性と有効性：ロシアでのランダム化比較第3相試験の中間分析 2021/02/02 https://t.co/JHsbNQSVGW 翻訳ソフトによる https://t.co/mJ1mWmYCWX
RT @Yoh_Yasushi: #Yoh_Yasushi_Check #ロシア からアデノウイルスベクターの #rAd26 #rAd5 の結果。 Safety and efficacy of an rAd26 and rAd5 vector-based heterolog…
#Yoh_Yasushi_Check #ロシア からアデノウイルスベクターの #rAd26 #rAd5 の結果。 Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysi… https://t.co/nRwuqVJ3xr
Refencias https://t.co/z93s87eL4q https://t.co/sc22bCNWKh https://t.co/xFXFFMwVyI https://t.co/k4IT1k6Qlw https://t.co/zaEsxwV3TA https://t.co/rOKjXPxVzr (3/3) https://t.co/q3gsgvWoKu
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @Ariel_em_Sampa: y aquí están los datos duros publicados como información complementaria del paper: https://t.co/DKmv51JoVZ
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
The Russian Sputnik against the Chinese Virus https://t.co/3fGPWwAFCF #coronahh #CoronaVirusDE #CoronaInfoCH #CoronaVirusAT https://t.co/JqytixXJj6
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
SPUTNIK V VACCINE #COVID19 92% eficacia Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/WGw2gjAhXj https://t.co/SDC4wMj9Yx
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
https://t.co/9B9keDbF5E
RT @Ariel_em_Sampa: y aquí están los datos duros publicados como información complementaria del paper: https://t.co/DKmv51JoVZ
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
y aquí están los datos duros publicados como información complementaria del paper: https://t.co/DKmv51JoVZ
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
A system-wide approach to stopping the COVID-19 pandemic requires the introduction of different vaccines based on different mechanisms of action to cover diverse global health demands with cost-effective and region-tailored methods. https://t.co/gvQIlnGvMR
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
@Fanxingyeh @valenteher @joeytijuana @RobertoLandey @doctormacias Ese ni siquiera es el estudio, es un comentario también publicado en The Lancet sobre el estudio en cuestión. https://t.co/6aUhZymPa1
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @StratCons: @TheLancet Resultados de #SputnikV @TheLancet Published online February 2, 2021 https://t.co/hWemj01GMR https://t.co/YF0A5…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
https://t.co/Wsgx6GoJAO Espero sepan leer culeros.
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
RT @profshanecrotty: SIX successful COVID-19 vaccines! SIX! Three just in the past week! Extraordinary. The newest one is the Russian (Rus)…
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/fulltext